EVAR POST-IMPLANTATION SYNDROME – CAN HEMATOLOGICAL VALUES HELP US?
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
DOI: | 10.48750/acv.322 |
Texto Completo: | https://doi.org/10.48750/acv.322 |
Resumo: | Introduction: Post-implantation syndrome (PIS) is the clinical and biochemical expression of an inflammatory response following endovascular repair of an aortic aneurysm (EVAR). The reported incidence in literature varies from 14-60%. Recentently, a study has demonstrated that red blood cell distribution width (RDW) is an independent biomarker predictor of the PIS in patients submitted to EVAR in the early postoperative period. Methods: Retrospective institutional review of consecutive patients submitted to elective EVAR (January 2015- April 2020). The primary outcome was to evaluate the incidence of PIS, defined as fever (>38ºC) and leukocytosis (>12000/μL), excluding infection complication. The secondary outcomes were to identify the potential role of clinical and biomarker parameters to predict the risk of developing PIS after EVAR. Results and conclusion: According to the inclusion criteria, 107 patients were identified. The median age was 75 years old (93.5% men). Comorbidities presented: hypertension (75%), smoking (66%), hypercholesterolemia (59%), coronary artery disease (32%), chronic kidney disease (30%), and diabetes mellitus (DM) (18%). The incidence of PIS was 10,2%. Age, gender and cardiovascular risk factors were found to be similar in both groups (P>0.05). Regarding the procedure approach, the majority of patients were treated with percutaneous access (72%) (P=0,49). In both groups (PIS vs. no PIS), the hemoglobin values significantly decreased (P=0,04) after surgery by approximately 14%. The same trend was observed for mean corpuscular volume (MCV) (P=0.032), which reflected the increasing of the RDW although not reaching statistical significance. Although delta variation of hemoglobin and delta RDW did not reach statistical significance comparing both groups (P=0,53 and P= 0,07 respectively), delta MCV was found to be significantly lower in the group with PIS (P=0.012). The importance of having a biomarker which measurement allows the prediction of patients who have more risk to develop PIS, may help with the early management of this condition. |
id |
RCAP_fa0d669240f9861bf0a46e7c628ff799 |
---|---|
oai_identifier_str |
oai:ojs.acvjournal.com:article/322 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
EVAR POST-IMPLANTATION SYNDROME – CAN HEMATOLOGICAL VALUES HELP US?SÍNDROME PÓS-IMPLANTAÇÃO APÓS EVAR - PODEM OS VALORES HEMATOLÓGICOS SER UTÉIS?InflamaçãoSíndrome de resposta inflamatóriaAneurisma da aortaProcedimentos endovascularesHemoglobinaVolume corpuscular médioAmplitude de distribuição dos glóbulos vermelhosIntroduction: Post-implantation syndrome (PIS) is the clinical and biochemical expression of an inflammatory response following endovascular repair of an aortic aneurysm (EVAR). The reported incidence in literature varies from 14-60%. Recentently, a study has demonstrated that red blood cell distribution width (RDW) is an independent biomarker predictor of the PIS in patients submitted to EVAR in the early postoperative period. Methods: Retrospective institutional review of consecutive patients submitted to elective EVAR (January 2015- April 2020). The primary outcome was to evaluate the incidence of PIS, defined as fever (>38ºC) and leukocytosis (>12000/μL), excluding infection complication. The secondary outcomes were to identify the potential role of clinical and biomarker parameters to predict the risk of developing PIS after EVAR. Results and conclusion: According to the inclusion criteria, 107 patients were identified. The median age was 75 years old (93.5% men). Comorbidities presented: hypertension (75%), smoking (66%), hypercholesterolemia (59%), coronary artery disease (32%), chronic kidney disease (30%), and diabetes mellitus (DM) (18%). The incidence of PIS was 10,2%. Age, gender and cardiovascular risk factors were found to be similar in both groups (P>0.05). Regarding the procedure approach, the majority of patients were treated with percutaneous access (72%) (P=0,49). In both groups (PIS vs. no PIS), the hemoglobin values significantly decreased (P=0,04) after surgery by approximately 14%. The same trend was observed for mean corpuscular volume (MCV) (P=0.032), which reflected the increasing of the RDW although not reaching statistical significance. Although delta variation of hemoglobin and delta RDW did not reach statistical significance comparing both groups (P=0,53 and P= 0,07 respectively), delta MCV was found to be significantly lower in the group with PIS (P=0.012). The importance of having a biomarker which measurement allows the prediction of patients who have more risk to develop PIS, may help with the early management of this condition.Introdução: A síndrome pós-implantação (SPI) é a expressão clínica e bioquímica de uma resposta inflamatória que se segue à reparação endovascular de um aneurisma da aorta abdominal (EVAR). A incidência reportada na literatura varia de 14-60%. Recentemente, um estudo demonstrou que a amplitude de distribuição dos glóbulos vermelhos (RDW) é um preditor independente do síndrome pós-implantação em pacientes submetidos a EVAR. Métodos: Estudo retrospectivo institucional de doentes submetidos a EVAR electivo (janeiro 2015 – abril 2020). Objetivo primário: avaliação da incidência de SPI – definido por febre (>38º) e leucocitose (>12000/μL), excluindo processo infeccioso concomitante. Objetivo secundário: identificação do papel de parâmetros clínicos e analíticos na predição do risco de desenvolimento de SPI após um EVAR. Resultados e conclusão: Inseridos 107 doentes, de acordo com os critérios. Idade mediana de 75 anos (93,5% sexo masculino). Comorbilidades presentes: HTA (75%), tabagismo (66%); dislipidemia (59%), doença coronária (32%), doença renal crónica (30%) e DM (18%). A incidência de SPI foi de 10,2%. Ambos os grupos eram semelhantes em relação à idade, sexo e fatores de risco cardiovasculares (P>0.05). Relativamente ao procedimento, a maioria dos casos foi tratada por acesso percutâneo (72%), que não teve influência relativamente ao desenvolvimento de SPI (P=0,49). Em ambos os grupos (SPI e sem SPI), os valores de hemoglobina desceram significativamente (P=0,04) após a intervenção, em 14%. A mesma tendência foi observada para os valores de volume corpuscular médio (MCV) (P=0.032), o que se reflectiu no aumento do RDW, embora este último não tenha atingido valores com significância estatística. Embora a variação delta da hemoglobin e o delta do RDW não tenham atingido significância estatística comparando ambos os grupos (P=0,53 e P=0,07 respectivamente), o delta do MCV foi significativamente menor no grupo de doentes com SPI (P=0,012). A existência de marcadores analíticos na predição dos doentes que têm maior risco de desenvolvimento de SPI é de grande importância, para a melhor orientação desta entidade o mais precocemente possível.Sociedade Portuguesa de Angiologia e Cirurgia Vascular2021-03-05T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://doi.org/10.48750/acv.322oai:ojs.acvjournal.com:article/322Angiologia e Cirurgia Vascular; Vol. 16 No. 4 (2020): December; 285-289Angiologia e Cirurgia Vascular; Vol. 16 N.º 4 (2020): Dezembro; 285-2892183-00961646-706Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPenghttp://acvjournal.com/index.php/acv/article/view/322https://doi.org/10.48750/acv.322http://acvjournal.com/index.php/acv/article/view/322/216Copyright (c) 2021 Angiologia e Cirurgia Vascularinfo:eu-repo/semantics/openAccessAugusto, RitaCoelho, NunoSemião, AnaPinto, EveliseRibeiro, JoãoPeixoto, JoãoFernandes, LuísBrandão, DanielCanedo, Alexandra2022-05-23T15:10:10Zoai:ojs.acvjournal.com:article/322Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T14:57:41.190198Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
EVAR POST-IMPLANTATION SYNDROME – CAN HEMATOLOGICAL VALUES HELP US? SÍNDROME PÓS-IMPLANTAÇÃO APÓS EVAR - PODEM OS VALORES HEMATOLÓGICOS SER UTÉIS? |
title |
EVAR POST-IMPLANTATION SYNDROME – CAN HEMATOLOGICAL VALUES HELP US? |
spellingShingle |
EVAR POST-IMPLANTATION SYNDROME – CAN HEMATOLOGICAL VALUES HELP US? EVAR POST-IMPLANTATION SYNDROME – CAN HEMATOLOGICAL VALUES HELP US? Augusto, Rita Inflamação Síndrome de resposta inflamatória Aneurisma da aorta Procedimentos endovasculares Hemoglobina Volume corpuscular médio Amplitude de distribuição dos glóbulos vermelhos Augusto, Rita Inflamação Síndrome de resposta inflamatória Aneurisma da aorta Procedimentos endovasculares Hemoglobina Volume corpuscular médio Amplitude de distribuição dos glóbulos vermelhos |
title_short |
EVAR POST-IMPLANTATION SYNDROME – CAN HEMATOLOGICAL VALUES HELP US? |
title_full |
EVAR POST-IMPLANTATION SYNDROME – CAN HEMATOLOGICAL VALUES HELP US? |
title_fullStr |
EVAR POST-IMPLANTATION SYNDROME – CAN HEMATOLOGICAL VALUES HELP US? EVAR POST-IMPLANTATION SYNDROME – CAN HEMATOLOGICAL VALUES HELP US? |
title_full_unstemmed |
EVAR POST-IMPLANTATION SYNDROME – CAN HEMATOLOGICAL VALUES HELP US? EVAR POST-IMPLANTATION SYNDROME – CAN HEMATOLOGICAL VALUES HELP US? |
title_sort |
EVAR POST-IMPLANTATION SYNDROME – CAN HEMATOLOGICAL VALUES HELP US? |
author |
Augusto, Rita |
author_facet |
Augusto, Rita Augusto, Rita Coelho, Nuno Semião, Ana Pinto, Evelise Ribeiro, João Peixoto, João Fernandes, Luís Brandão, Daniel Canedo, Alexandra Coelho, Nuno Semião, Ana Pinto, Evelise Ribeiro, João Peixoto, João Fernandes, Luís Brandão, Daniel Canedo, Alexandra |
author_role |
author |
author2 |
Coelho, Nuno Semião, Ana Pinto, Evelise Ribeiro, João Peixoto, João Fernandes, Luís Brandão, Daniel Canedo, Alexandra |
author2_role |
author author author author author author author author |
dc.contributor.author.fl_str_mv |
Augusto, Rita Coelho, Nuno Semião, Ana Pinto, Evelise Ribeiro, João Peixoto, João Fernandes, Luís Brandão, Daniel Canedo, Alexandra |
dc.subject.por.fl_str_mv |
Inflamação Síndrome de resposta inflamatória Aneurisma da aorta Procedimentos endovasculares Hemoglobina Volume corpuscular médio Amplitude de distribuição dos glóbulos vermelhos |
topic |
Inflamação Síndrome de resposta inflamatória Aneurisma da aorta Procedimentos endovasculares Hemoglobina Volume corpuscular médio Amplitude de distribuição dos glóbulos vermelhos |
description |
Introduction: Post-implantation syndrome (PIS) is the clinical and biochemical expression of an inflammatory response following endovascular repair of an aortic aneurysm (EVAR). The reported incidence in literature varies from 14-60%. Recentently, a study has demonstrated that red blood cell distribution width (RDW) is an independent biomarker predictor of the PIS in patients submitted to EVAR in the early postoperative period. Methods: Retrospective institutional review of consecutive patients submitted to elective EVAR (January 2015- April 2020). The primary outcome was to evaluate the incidence of PIS, defined as fever (>38ºC) and leukocytosis (>12000/μL), excluding infection complication. The secondary outcomes were to identify the potential role of clinical and biomarker parameters to predict the risk of developing PIS after EVAR. Results and conclusion: According to the inclusion criteria, 107 patients were identified. The median age was 75 years old (93.5% men). Comorbidities presented: hypertension (75%), smoking (66%), hypercholesterolemia (59%), coronary artery disease (32%), chronic kidney disease (30%), and diabetes mellitus (DM) (18%). The incidence of PIS was 10,2%. Age, gender and cardiovascular risk factors were found to be similar in both groups (P>0.05). Regarding the procedure approach, the majority of patients were treated with percutaneous access (72%) (P=0,49). In both groups (PIS vs. no PIS), the hemoglobin values significantly decreased (P=0,04) after surgery by approximately 14%. The same trend was observed for mean corpuscular volume (MCV) (P=0.032), which reflected the increasing of the RDW although not reaching statistical significance. Although delta variation of hemoglobin and delta RDW did not reach statistical significance comparing both groups (P=0,53 and P= 0,07 respectively), delta MCV was found to be significantly lower in the group with PIS (P=0.012). The importance of having a biomarker which measurement allows the prediction of patients who have more risk to develop PIS, may help with the early management of this condition. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-03-05T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://doi.org/10.48750/acv.322 oai:ojs.acvjournal.com:article/322 |
url |
https://doi.org/10.48750/acv.322 |
identifier_str_mv |
oai:ojs.acvjournal.com:article/322 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
http://acvjournal.com/index.php/acv/article/view/322 https://doi.org/10.48750/acv.322 http://acvjournal.com/index.php/acv/article/view/322/216 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2021 Angiologia e Cirurgia Vascular info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2021 Angiologia e Cirurgia Vascular |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Sociedade Portuguesa de Angiologia e Cirurgia Vascular |
publisher.none.fl_str_mv |
Sociedade Portuguesa de Angiologia e Cirurgia Vascular |
dc.source.none.fl_str_mv |
Angiologia e Cirurgia Vascular; Vol. 16 No. 4 (2020): December; 285-289 Angiologia e Cirurgia Vascular; Vol. 16 N.º 4 (2020): Dezembro; 285-289 2183-0096 1646-706X reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1822218875696054272 |
dc.identifier.doi.none.fl_str_mv |
10.48750/acv.322 |